ISSN 2407-2230 | E-ISSN 1907-3062 | Universa Medicina content is searchable on DOAJ, Google Scholar, and OAI

High Framingham risk score decreases quality of life in adults

Christian Yosaputra, Erica Kholinne, Erick Susanto Taufik
Submission date: Thursday, 25 February 2016
Published date: Thursday, 25 February 2016
DOI: http://dx.doi.org/10.18051/UnivMed.2010.v29.27-33

Abstract


Cardiovascular disease (CVD) risk factors, such as diabetes, hypertension, hypercholesterolemia,  smoking, and obesity tend to occur together in the general population. Increasing prevalence of multiple CVD risk factors has been related to increased risk of death from coronary heart disease and stroke. Studies have suggested that people with several risk factors of CVD may have impaired health-related quality of life. The objective of this study was to assess the association of CVD risk factors with quality of life (QOL) among adults aged 40 to 65 years. A cross-sectional study was conducted involving  220 subjects 40 - 65 years of age at a health center. The CVD risk factors were assessed using the Framingham risk score that is the standard instrument for assessment of the risk of a first cardiac event. The risk factors assessed were age, smoking, blood pressure, total cholesterol and high density lipoprotein cholesterol concentrations. QOL was assessed by means of the WHOQOL-BREF instrument that had been prevalidated. The results of the study showed that 28.2% of subjects were smokers, 56.4% had stage 1 hypertension, 42.8% high total cholesterol and 13.6% low HDL cholesterol. The high risk group amounted to 45.5% and 42.3% constitued an intermediate risk group. High CVD risk scores were significantly associated with a low QOL for all domains (physical, psychological, social and environment) (p=0.000). Preventing or reducing the multiple CVD risk factors to improve QOL is necessary among adults.

Keywords


Framingham risk score; quality of life; adult

Full Text:

PDF

References


McKay J, Mensah GA. The atlas of heart disease and stroke. Geneva: World Health Organization; 2004.

Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL. Selected major risk factors and global and regional burden of disease. Lancet 2002;360:1347-60.

Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part I: general considerations, the epidemiological transition, risk factors, and impact of urbanization. Circulation 2001;104:2746-53.

McDermott MM. The international pandemic of chronic cardiovascular disease. JAMA 2007;297: 1253-5.

Bovet P, Shamlaye C, Gabriel A, Riesen W, Paccaud F. Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy. BMC Public Health 2006;6:9.

Badan Penelitian dan Pengembangan Kesehatan Departemen Kesehatan Republik Indonesia. Laporan nasional 2007: riset kesehatan dasar (Riskesdas). Jakarta: Badan Penelitian dan Pengembangan Kesehatan Departemen Kesehatan Republik Indonesia;2008.

D’Agostino RB, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001; 286:180-7.

Wilson PWF, D’Agustino RB, Levy D, Balenger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 2005;97:1837-47.

Benjak T, Mavrinac GV. Subjective quality of life and cadiovascular risk factors in a Croatian adult population. Coll Antropol 2009;33:159-63.

Coelho R, Amorin I, Prata J. Coping styles and quality of life in patients with non-insulin-dependent diabetes mellitus. Psychosomatics 2003;44:312-8.

The WHOQOL Group Development of the World Health Organisation. WHOQOL-BREF quality of life assessment. Psychol Med 1998;28:51–8.

Stamler J, Daviglus M, Garside M. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA 2000;284:311-8.

Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343:16-22.

Lauer MS, Fontanarosa PB. Updated guidelines for cholesterol management. JAMA 2001;285: 2508-09.

Ramachandran S, French JM, Vanderpump MPJ, Croft P, Neary RH. Using the Framingham model to predict heart disease in the United Kingdom: a retrospective study. Br Med J 2000;320:676-7.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. and the National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension;2003;42:1206–52.

Salim OC, Sudharma NI, Kusumaratna RK, Hidayat A. Validity and reliability of World Health Organization Quality of Life-BREF to assess the quality of life in the elderly. Univ Med 2007;26:27-38.

Greenland P, Labree C, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk reduction in asymptomatic individuals. JAMA 2004;291:210-5.

Daviglus ML, Liu K, Pirzada A, Yan LL, Garside DB, Feinglass J, et al. Favorable cardiovascular risk profile in middle age and health-related quality of life in older age. Arch Intern Med 2003; 163:2460-8.

Chambers BA, Guo SS, Siervogel R. Cumulative effects of cardiovascular disease risk factors on quality of life. J Nutr Health Aging 2002;6:179–84.

Oldridge NB, Stump TE, Nothwehr FK, Clark DO. Prevalence and outcomes of comorbid metabolic and cardiovascular conditions in middle and older age adults. J Clin Epidemiol 2001;54:928–34.

Wee HL, Cheung YB, Li SC. The impact of diabetes mellitus and other chronic medical conditions on health-related quality of life: is the whole greater than the sum of its parts? Health Qual Life Outcomes 2005;3:2.

Li C, Ford ES, Mokdad AH, Balluz LS, Brown DW, Giles WH. Clustering of cardiovascular disease risk factors and health-related quality of life among US adults. Value Health 2008;11:689–99.

Erikssoni KM, Westborg CJ, Eliasson MCE. A randomized trial of lifestyle intervention in primary healthcare for the modification of cardiovascular risk factors : the Bjo¨rkna¨ s study. Scand J Public Health 2006;34:453–61.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Universa Medicina



Creative Commons License
Universa Medicina by Faculty of Medicine, Trisakti University is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Based on a work at https://univmed.org/ejurnal/index.php/medicina/